George L. Sing, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 4,900 shares at $455.00 ($2.2M) on 2020-02-26, disclosed to the SEC on 2020-02-28.
Open-market sale of $2.2M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $450.00 | 400 | $180K | 8.0% |
| 2 | $450.00 | 300 | $135K | 6.0% |
| 3 | $450.00 | 500 | $225K | 10.1% |
| 4 | $455.00 | 500 | $228K | 10.2% |
| 5 | $455.00 | 300 | $137K | 6.1% |
| 6 | $457.00 | 400 |
| $183K |
| 8.2% |
| 7 | $460.00 | 2,500 | $1.1M | 51.4% |
| Total | $456.49 avg | 4,900 | $2.2M | 100% |
| Filing → |
| REGN | SELL | 2024-02-12 | $950K | — | Filing → |
| REGN | SELL | 2022-03-01 | $2.5M | — | Filing → |
| REGN | SELL | 2021-11-23 | $2.0M | — | Filing → |